Page 1

Replimune Vusolimogene oderparepvec - wtpg ( TUDRIQEV ™ ) in Combination with Nivolumab for the Treatment of Adults with Unresectable Advanced Cutaneous Melanoma United States Food and Drug Administration Cellular , Tissue and Gene Therapies Advisory Committee July 30 , 2026 CC - 1